Jason A. Okazaki
Net Worth
Last updated:
What is Jason A. Okazaki net worth?
The estimated net worth of Mr. Jason A. Okazaki is at least $2,583,047 as of 3 Oct 2024. He owns shares worth $375,581 as insider, has earned $97,656 from insider trading and has received compensation worth at least $2,109,810 in Assembly Biosciences, Inc..
What is the salary of Jason A. Okazaki?
Mr. Jason A. Okazaki salary is $703,270 per year as Chief Operating Officer in Assembly Biosciences, Inc..
How old is Jason A. Okazaki?
Mr. Jason A. Okazaki is 49 years old, born in 1976.
What stocks does Jason A. Okazaki currently own?
As insider, Mr. Jason A. Okazaki owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | Chief Operating Officer | 14,904 | $25.2 | $375,581 |
What does Assembly Biosciences, Inc. do?
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Jason A. Okazaki insider trading
Assembly Biosciences, Inc.
Mr. Jason A. Okazaki has made 13 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 197 units of ASMB stock worth $2,918 on 3 Oct 2024.
The largest trade he's ever made was exercising 11,827 units of ASMB stock on 2 Aug 2023. As of 3 Oct 2024 he still owns at least 14,904 units of ASMB stock.
Assembly Biosciences key executives
Assembly Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. John G. McHutchison A.O., FRACP, M.D. (68) Chief Executive Officer, Pres & Director
- Dr. William E. Delaney IV, Ph.D. (53) Chief Scientific Officer
- Mr. Jason A. Okazaki (49) Chief Operating Officer